Save your place

Sign in to WhoBought

Please try again later.

REGENXBIO Inc. (RGNX) institutional ownership

Latest close $10.34 Jul 21, 2026
Market cap$413M 52-week range SectorHealthcare
Funds holding · Q1 2026
173
reported RGNX position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
90 buyers · 83 sellers

REGENXBIO Inc. (RGNX) price and institutional activity

Dates

Q1 2026

$0 bought by 90 investors
Qube Research & Technologies LtdState Street +88 more
$0 sold by 83 investors
22nw, LPAcadian Asset Management LLC +81 more
Bought Sold Totals per quarter; hover a bar for the names.

REGENXBIO Inc. (RGNX) institutional activity · 83

Investor Type Est. change Change Δ Own Date
22nw, LP · Reduced
Change −431K Date Q1 2026
22nw, LP Reduced· Q1 2026 −431K Q1 2026
Acadian Asset Management LLC · Reduced
Change −372K Date Q1 2026
Acadian Asset Management LLC Reduced· Q1 2026 −372K Q1 2026
AQR Capital Management LLC · Reduced
Change −310K Date Q1 2026
AQR Capital Management LLC Reduced· Q1 2026 −310K Q1 2026
Trexquant Investment LP · Exited
Change −251K Δ Own −100.0% Date Q1 2026
Trexquant Investment LP Exited· Q1 2026 −251K −100.0% Q1 2026
Moore Capital Management, LP · Exited
Change −200K Δ Own −100.0% Date Q1 2026
Moore Capital Management, LP Exited· Q1 2026 −200K −100.0% Q1 2026
Assenagon Asset Management S.A. · Reduced
Change −180K Date Q1 2026
Assenagon Asset Management S.A. Reduced· Q1 2026 −180K Q1 2026
Panagora Asset Management Inc · Reduced
Change −121K Date Q1 2026
Panagora Asset Management Inc Reduced· Q1 2026 −121K Q1 2026
Royce & Associates LP · Exited
Change −119K Δ Own −100.0% Date Q1 2026
Royce & Associates LP Exited· Q1 2026 −119K −100.0% Q1 2026
Propel Bio Management, LLC · Exited
Change −117K Δ Own −100.0% Date Q1 2026
Propel Bio Management, LLC Exited· Q1 2026 −117K −100.0% Q1 2026
American Century Companies Inc · Exited
Change −113K Δ Own −100.0% Date Q1 2026
American Century Companies Inc Exited· Q1 2026 −113K −100.0% Q1 2026
Adar1 Capital Management, LLC · Reduced
Change −100K Date Q1 2026
Adar1 Capital Management, LLC Reduced· Q1 2026 −100K Q1 2026
Barclays PLC · Reduced
Change −97K Date Q1 2026
Barclays PLC Reduced· Q1 2026 −97K Q1 2026
Jane Street Group, LLC · Reduced
Change −91K Date Q1 2026
Jane Street Group, LLC Reduced· Q1 2026 −91K Q1 2026
Nuveen, LLC · Reduced
Change −76K Date Q1 2026
Nuveen, LLC Reduced· Q1 2026 −76K Q1 2026
JPMorgan Chase & Co · Reduced
Change −70K Date Q1 2026
JPMorgan Chase & Co Reduced· Q1 2026 −70K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 83

Famous investor activity in REGENXBIO Inc. (RGNX)

REGENXBIO Inc. (RGNX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Pakola Steve · Officer Sell −$29K
Price $13.64 Qty −2K Owned 213K ΔOwn −1.0% Trade date Jul 2, 2026 Filed date Jul 6, 2026
Pakola Steve Officer Sell $13.64 −2K −$29K 213K −1.0% Jul 2, 2026 Jul 6, 2026
Pakola Steve · Officer 2 operations 0
Price $7.86 Owned 65K Trade date Jul 2, 2026 Filed date Jul 6, 2026
Pakola Steve Officer 2 operations $7.86 0 65K Jul 2, 2026 Jul 6, 2026
Simpson Curran · Director Tax withholding or exercise payment (F) -$89K
Price $13.09 Qty -7K Owned 338K ΔOwn −2.0% Trade date Jul 1, 2026 Filed date Jul 6, 2026
Simpson Curran Director Tax withholding or exercise payment (F) $13.09 -7K -$89K 338K −2.0% Jul 1, 2026 Jul 6, 2026
Pakola Steve · Officer Sell −$472K
Price $12.86 Qty −37K Owned 213K ΔOwn −14.7% Trade date Jul 1, 2026 Filed date Jul 1, 2026
Pakola Steve Officer Sell $12.86 −37K −$472K 213K −14.7% Jul 1, 2026 Jul 1, 2026
Pakola Steve · Officer 2 operations 0
Price $7.86 Owned 67K Trade date Jul 1, 2026 Filed date Jul 1, 2026
Pakola Steve Officer 2 operations $7.86 0 67K Jul 1, 2026 Jul 1, 2026
Simpson Curran · Director Grant (A) $15K
Price $10.18 Qty 1K Owned 345K ΔOwn +0.4% Trade date Jun 30, 2026 Filed date Jul 6, 2026
Simpson Curran Director Grant (A) $10.18 1K $15K 345K +0.4% Jun 30, 2026 Jul 6, 2026
Pakola Steve · Officer Sell −$216K
Price $11.04 Qty −20K Owned 213K ΔOwn −8.4% Trade date Jun 29, 2026 Filed date Jul 1, 2026
Pakola Steve Officer Sell $11.04 −20K −$216K 213K −8.4% Jun 29, 2026 Jul 1, 2026
Tasse Daniel · Director 2 operations 56K
Owned 47K Trade date May 29, 2026 Filed date Jun 2, 2026
Tasse Daniel Director 2 operations 56K 47K May 29, 2026 Jun 2, 2026
Stump David C. · Director 2 operations 56K
Owned 47K Trade date May 29, 2026 Filed date Jun 2, 2026
Stump David C. Director 2 operations 56K 47K May 29, 2026 Jun 2, 2026
Zachary Jennifer · Director 2 operations 56K
Owned 47K Trade date May 29, 2026 Filed date Jun 2, 2026
Zachary Jennifer Director 2 operations 56K 47K May 29, 2026 Jun 2, 2026
Mills Kenneth T. · Director 2 operations 56K
Owned 47K Trade date May 29, 2026 Filed date Jun 2, 2026
Mills Kenneth T. Director 2 operations 56K 47K May 29, 2026 Jun 2, 2026
Migausky George V · Director 2 operations 56K
Owned 47K Trade date May 29, 2026 Filed date Jun 2, 2026
Migausky George V Director 2 operations 56K 47K May 29, 2026 Jun 2, 2026
Karabelas Argeris N. · Director 2 operations 56K
Owned 47K Trade date May 29, 2026 Filed date Jun 2, 2026
Karabelas Argeris N. Director 2 operations 56K 47K May 29, 2026 Jun 2, 2026
Glucksmann Alexandra · Director 2 operations 56K
Owned 47K Trade date May 29, 2026 Filed date Jun 2, 2026
Glucksmann Alexandra Director 2 operations 56K 47K May 29, 2026 Jun 2, 2026
Fox Allan M. · Director 2 operations 56K
Owned 47K Trade date May 29, 2026 Filed date Jun 2, 2026
Fox Allan M. Director 2 operations 56K 47K May 29, 2026 Jun 2, 2026
15 of 38
15 of 38 Sign in to continue to older insider transactions.

REGENXBIO Inc. (RGNX) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
BlackRock Inc. 8.2M
% of shares outstanding 18.7% Filing date Jan 19, 2024
BlackRock Inc. 8.2M 18.7% Jan 19, 2024
Redmile Group, LLC 4.9M
% of shares outstanding 9.9% Filing date Nov 14, 2024
Redmile Group, LLC 4.9M 9.9% Nov 14, 2024
Vanguard Group Inc 4.4M
% of shares outstanding 8.8% Filing date Nov 12, 2024
Vanguard Group Inc 4.4M 8.8% Nov 12, 2024
State Street Corporation 2.7M
% of shares outstanding 5.3% Filing date May 12, 2026
State Street Corporation 2.7M 5.3% May 12, 2026
JPMorgan Chase & Co 2.3M
% of shares outstanding 4.4% Filing date Jun 4, 2026
JPMorgan Chase & Co 2.3M 4.4% Jun 4, 2026
GIC Private Ltd 1.0M
% of shares outstanding 2.4% Filing date Feb 5, 2024
GIC Private Ltd 1.0M 2.4% Feb 5, 2024
6 of 6

REGENXBIO Inc. (RGNX) ownership FAQ

Who owns RGNX?

173 reporting institutions disclosed RGNX position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.